HBI Deals+Insights / Healthcare Reform
The number of dialysis patients treated by Diaverum and DaVita in Saudi Arabia nearly doubled in 2017, while the overall dialysis population grew double-digits and will do so again in 2018, according to an official report. Based on session payment rates reported by HBI, the 2017 market was worth around US$800m.